Delivery Order SPE2DB24D2205-SPE2DB25FEJBD
- Not listed
- The Defense Logistics Agency awarded a $13,862.79 delivery order to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count units) on September 10, 2025, with an ultimate completion date of October 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Zeposia 0.92 mg capsules (30-count packages) with a contract ceiling value of $13,862.79. This firm fixed-price delivery order is scheduled for completion by October 2, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules in a 30-count package under a firm fixed-price contract valued at $13,862.79. The award, announced on August 4, 2025, with completion targeted for August 25, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zeposia 0.92 mg capsules (30-count) with a ceiling value of $13,862.79. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by August 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical distributor, AmerisourceBergen maintains a...
- The Defense Logistics Agency awarded a $4,620.93 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,862.79 to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count) on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a contract value of $4,620.93. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by September 25, 2025. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $13,862.79 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract. The award was issued on July 29, 2025, with an ultimate completion date of August 19, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4,620.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This non-set-aside delivery order, with an ultimate completion date of October 10, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $9,241.86. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEJBDDelivery Order
The Defense Logistics Agency awarded a $41,588.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count units) on September 25, 2025, with completion required by October 17, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Zeposia is a specialty immunosuppressant medication used in the treatment of multiple sclerosis and ulcerative colitis, reflecting the Defense Health Agency's need to maintain adequate inventory of specialized therapeutics for eligible military beneficiaries and service members. AmerisourceBergen's established position as a prime pharmaceutical vendor to the DLA, combined with its demonstrated capability to deliver competitively across diverse medication categories and therapeutic domains, positions the company as a critical supplier within the federal medical supply chain. The delivery order pricing structure and compressed delivery timeline underscore the operational demand for maintaining adequate pharmaceutical stockpiles across military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.6k | 9/25/25 |